SMARCA4 and prostate carcinoma: Furthermore, the interaction of OTUD6A with Brg1 and AR was also verified in other prostate cancer cell lines, including PC-3, LNCaP, and C4-2 cells, through IP-IB analysis (Supplementary Fig. 4d, e).